cp-55,940 has been researched along with sr 144528 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brockie, HC; Makriyannis, A; Murphy, VL; Pertwee, RG; Ross, RA; Stevenson, LA; Templeton, F | 1 |
| Gilliam, AF; Hurst, DP; Kotsikorou, E; Kumar, P; Lynch, DL; Navas, F; Reggio, PH; Roche, MJ; Seltzman, HH; Song, ZH; Thomas, BF | 1 |
| Cooper, AG; Glass, M; Hook, S; MacDonald, C; Tyndall, JDA; Vernall, AJ | 1 |
| Alghamdi, SS; Moore Ii, BM; Mustafa, SM | 1 |
4 other study(ies) available for cp-55,940 and sr 144528
| Article | Year |
|---|---|
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
Topics: Animals; Benzoxazines; Binding, Competitive; Camphanes; Cannabinoids; CHO Cells; Chromans; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Tritium | 1999 |
The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carbox
Topics: Camphanes; Hydrogen Bonding; Models, Molecular; Pyrazoles; Radioligand Assay; Receptor, Cannabinoid, CB2 | 2013 |
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.
Topics: Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Ligands; Models, Molecular; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2018 |
Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189.
Topics: Animals; Benzophenones; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |